Vasodilator therapy of portal hypertension: Focus on the liver
✍ Scribed by Andres T. Blei
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 482 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We describe three patients referred for orthotopic liver transplantation with liver failure and portal hypertension who were found to have malignant vascular tumors: two patients with angiosarcoma and one patient with epithelioid hemangioendothelioma. Their clinical presentation mimicked decompensat
## Abstract The purpose of this study was to prospectively investigate the extent to which reduced portal blood flow in patients with hepatic cirrhosis and portal hypertension affects hepatic parenchymal enhancement during gadolinium‐chelate‐enhanced dynamic MR imaging. Breath‐hold three‐dimensiona
The files of patients who underwent emergency endoscopy in a 2-yr period (January 1985 to January 1987) in the Heinz-Kalk Hospital were analyzed to establish the frequency, significance and therapy of the Mdlory-Weiss syndrome associated with portal hypertension, an association observed in 55 of 339
## Abstract β‐catenin functions as both a structural protein and a transcriptional activator. In this study, we examined the expression of β‐catenin in human cirrhotic livers, and administered adenoviruses carrying the β‐catenin or ΔTCF4 genes to cirrhotic rats to investigate the role of β‐catenin
## Abstract Portal hypertension has been described in a wide variety of hematological disorders, especially myeloproliferative and lymphoproliferative disorders. Its clinical manifestations may include bleeding esophageal varices, ascites, or hepatic encephalopathy. In patients with hematological d